VIVUS, Inc.

VIVUS, Inc. is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. VIVUS, Inc. is not very popular among insiders. Tradey thinks it is not wise to invest in VIVUS, Inc..
Log in to see more information.
VIVUS, Inc. engages in the development and commercialization of novel therapeutic products. The firm...

News